ENXTBR:ARGXBiotechs
A Look At argenx (ENXTBR:ARGX) Valuation Following The Recent Leadership Transition
argenx (ENXTBR:ARGX) is back in focus after a leadership reshuffle, with Chief Operating Officer Karen Massey set to become CEO and Executive Director as co founder Tim Van Hauwermeiren moves to non executive chairman.
See our latest analysis for argenx.
The leadership announcement came after a period of mixed momentum, with a 30 day share price return of a 9.29% decline but a 1 year total shareholder return of 8.5%, and longer term total shareholder returns over 3 and 5 years remaining...